(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.7% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Qiagen Nv's revenue in 2024 is $1,965,311,000.On average, 6 Wall Street analysts forecast QGEN's revenue for 2024 to be $456,864,882,146, with the lowest QGEN revenue forecast at $456,220,665,768, and the highest QGEN revenue forecast at $458,724,506,396. On average, 6 Wall Street analysts forecast QGEN's revenue for 2025 to be $484,946,600,365, with the lowest QGEN revenue forecast at $481,667,554,979, and the highest QGEN revenue forecast at $488,559,278,180.
In 2026, QGEN is forecast to generate $515,210,621,530 in revenue, with the lowest revenue forecast at $509,996,644,984 and the highest revenue forecast at $520,581,373,369.